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Introduction 
Generally, cardiovascular diseases (CVD) were found to be pri- 
mary source of mortality. Developing countries like India are 
also struggling to manage the impact of CVD along with the 
growing burden of obesity [1] . Heart disease is any disorder 
that disturbs the heart’s capability to function usually. Heart dis- 
ease is a general term that refers to a variety of acute and chronic 
medical conditions that affect one or more of the components of 
the heart [2] . Myocardial infarction (MI) or acute myocardial 
infarction (AMI), generally known as a heart attack, happens 
when the blood supply to portion of the heart is disturbed mak- 
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ing some heart cells to die. This is most commonly due to oc- 
clusion (blockage) of a coronary artery following the rupture of 
a vulnerable atherosclerotic plaque, which is an unstable collec- 
tion of lipids (like cholesterol) and white blood cells (especially 
macrophages) in the wall of an artery [3] . Isoproterenol [1-   
(3, 4- dinydropheny1)-2- isopropylamino ethanol hydrochloride] 
(ISO) a synthetic catecholamine and β-adrenergic agonist, is 
documented to cause severe oxidative stress in the myocardium 
and resulting in infarct like necrosis of the heart muscle [4] . 
Oxidative stress is a condition in which oxidant metabolites ex- 
ert their toxic effect because of an increased production or an 
altered cellular mechanism protection [5] . Increased oxidative 
stress and the generation of the free oxygen radicals can result 
in modification of Low- density lipoprotein (LDL) to oxidized 
Low-density lipoprotein (LDL) that could lead to atheroscle- 
 
 
 
Abstract 
The present study was executed to evaluate the myocardial protective effect of methanol extract of Bougainvillea glabra against 
isoproterenol induced myocardial necrosis in rats. Myocardial necrosis was induced by subcutaneous injection of isoproterenol 
(85mg/kg body weight) on 29th  and 30th  day at an interval of 24 hours. Myocardial necrosis was evident from the changes      
of marker enzymes in serum, plasma and heart tissue. The activities of serum cardiac marker enzymes such as lactate dehy- 
drogenase (LDH), creatine kinase myoglobin (CK-MB), serum glutamate oxaloacetate transaminase (SGOT), serum glutamate 
pyruvate transaminase (SGPT), triglycerides (TG), total cholesterol (TC), high density lipoproteins (HDL), low density lipopro- 
teins (LDL), very low density lipoproteins (VLDL) and total protein (TP) were estimated. In addition, plasma TBARS and plasma 
LDH levels were also recorded. Antioxidant parameters viz catalase (CAT), superoxide dismutase (SOD), glutathione (GSH), 
glutathione peroxidase (GPx) and malondialdehyde (MDA) levels were performed in heart tissue homogenate. The outcome of 
the study indicated that, pretreatment with methanol extract of Bougainvillea glabra to isoproterenol induced rats significantly 
prevented the altered serum cardiac marker enzymes, plasma levels and antioxidant parameters to near normal status. The car- 
dioprotective effect was compared with propranolol (10 mg/kg, oral) which was used as the standard. Histopathological findings 
exposed a reduced degree of necrosis and inflammation succeeding pretreatment with Bougainvillea glabra.Based on these re- 
sults, it was suggested that methanol extract of Bougainvillea glabra prevents myocardial necrosis and oxidative stress induced 
by isoproterenol. 
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rotic lesions. Many antioxidants like Vitamins C and E and plant 
polyphenols are efficient tools in oxidative stress and cardio- 
vascular disorders as potential therapeutic agents [6] . Various 
phytoconstituents like carotenoids, flavonoids, cardiac glyco- 
sides and alkaloids were responsible for cardioprotective activ- 
ity [7] [8] . Bougainvillea glabra is a useful medicinal plant from 
Nyctaginaceae family finding applications in indigenous sys- 
tems of medicine. Bougainvillea glabra is an ornamental plant 
with several medicinal properties. It is distributed everywhere, 
mostly in warm climatic regions. Bougainvillea glabra is having 
colorful flowers and the plant is seen in front of houses and in 
office and on walls and fences [9] . Leaves juice of Bougainvil- 
lea glabra is orally taken with rhizome juice of Curcuma caesia 
for a few days to treat helminthiasis in Bangladesh [10] . Var- 
ious pharmacological activities like antidiabetic [11] , antilipi- 
demic [12] and anthelmintic [13] were proved from Bougainvil- 
lea glabra. The phytochemical analysis of the extract reveals the 
presence of alkaloids, terpenoids, saponins and cardiac glyco- 
sides in Bougainvillea glabra. Five flavonoids were isolated and 
identified as vitexdin, isovitexin, chrysoeriol, apigenin and lute- 
olin from methanol extract of Bougainvillea glabra [14] . The 
GC-MS study of Bougainvillea glabra has shown many phy- 
tochemicals which contributes to the medicinal activity of the 
plant. Hence, the present study was dedicated on assessing the 
cardioprotective effects of methanol extract of Bougainvillea 
glabra on isoproterenol induced myocardial necrosis in wistar 
albino rats. 
 
Material  and Methods 
 
Chemicals 
All chemical substances used in the study stood analytical 
grade. Thiobarbituric acid, reduced glutathione, oxidized glu- 
tathione and propranolol were obtained from SD fine chemicals 
Ltd. (Mumbai, India). Isoproterenol was procured from Sigma 
Aldrich chemicals, USA. Serum biochemical parameters like to- 
tal cholesterol (TC), triglycerides (TG) and high density lipopro- 
tein (HDL), low density lipoprotein (LDL) and very low density 
lipoprotein (VLDL) were analyzed using commercially avail- 
able reagent methods. 
 
Collection and authentication of plant material 
The whole plant of Bougainvillea  glabra  (Nyctaginaceae)  
was collected in the month of July from botanical garden, 
Hanamkonda, Warangal district, Telangana, India. It was shade 
dried away from sunlight and stored suitably. The plant material 
was taxonomically identified by Dr. Vatsavaya S Raju, Professor, 
Plant Systematics Laboratory, Department of Botany,  Kakatiya 
University, Warangal district Telangana, India and a voucher 
specimen was deposited in the her barium against accession 
number 4610 for future reference. 
 
Extraction 
The whole plant of Bougainvillea glabra was powdered with a 
mechanical grinder and passed through Sieve no. 40. Powder of 
Bougainvillea glabra was extracted with methanol by continuous 
Soxhlet extraction method. The excess solvent was removed by 
rotary vacuum evaporator; the remaining mass of extract was 
concentrated and dried. The percentage yield of the extract was 
calculated. 
 
Experimental animals 
Albino rats of Wis tar strain (200-250gm) were procured from 
Ghost enterprises, Kolkata, India. All the rats were accommo- 
dated in polypropylene cages and preserved in a precise envi- 
ronment (28-32◦C) with 12-12 hr of light and dark cycle. Each 
day all the animals were fed a normal laboratory diet ad libi- 
tum and had free access to water. The protocol was approved by 
Institutional Animal Ethical Committee constituted for the pur- 
pose. CPCSEA Registration No:- 1287/PO/Re/S/09/CPCSEA. 
The animals were preserved under customary environments in 
an animal house as per the guidelines of committee for the 
purpose of control and supervision on experiments on animals 
(CPCSEA). 
 
Acute toxicity study 
Acute oral toxicity study in experimental rats was carried out as 
per OECD-423 guidelines. Four doses (10, 50, 300, 2000 mg/kg 
body weight) of methanol extract of Bougainvillea glabra were 
administered orally to groups containing three animals of the 
same age group and weight. The animals were regularly moni- 
tored for 1 hour continuously and then hourly for 4hr and finally 
after every 24hr up to 15 days for any symptoms of toxicity and 
mortality [15]. 
 
Experimental protocol 
A total of thirty rats were taken for the experiment. After ac- 
climatization, the animals were allocated into five groups con- 
taining six animals each. Group I animals received normal saline 
and termed as control group (1ml/kg/day p.o) for 30 days. Group 
II animals served as isoproterenol treated and received saline (1 
ml/kg, p.o.) daily for 30 days. Group III animals was treated 
with standard propranolol (10 mg/kg, p.o) for one week after 
two weeks of saline treatment. Group IV and Group V animals 
were pretreated with methanol extract of Bougainvillea glabra at 
250mg/kg and 500mg/kg BW by orally for 30 days respectively. 
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Animals from Group II to Group V were administered with iso- 
proterenol (ISO) 85mg/kg, sub cutaneous on 29th and 30th day 
at an interval of 24 hours [16]. All the animals were sacrificed 
by decapitation on 31st day of the experiment. The heart was 
removed, washed in cold saline and stored in liquid nitrogen for 
further biochemical studies. 
Estimation of Biochemical parameters 
Preparation of serum from blood 
The serum was separated by centrifugation at 2500 rpm at 30◦C 
for 15 min and it was used for the estimation of cardiac marker 
enzymes like creatine kinase myoglobin (CK-MB), serum glu- 
tamic oxaloacetic transaminase (SGOT), serum glutamic pyru- 
vic transaminase (SGPT), triglycerides (TG), total cholesterol 
(TC), high density lipoprotein (HDL), low density lipoprotein 
(LDL) and very low density lipoprotein (VLDL). 
Preparation of plasma from blood 
Plasma was obtained by cold centrifugation of blood samples  
at 3000 rpm for 10 minutes and used for estimation of plasma 
LDH, plasma TBARS and total protein. 
Preparation of heart homogenate 
The heart was dissected out, washed with ice-cold saline and    
a 10% homogenate was prepared in phosphate buffer (50 mm, 
pH 7.4). The homogenate was centrifuged at 7000 rpm for 15 
min and the supernatant was used for the assay of superoxide 
dismutase (SOD), catalase (CAT), reduced glutathione (GSH), 
glutathione peroxidise (GPx) and lipid peroxidation (MDA). 
Estimation of serum cardioprotective parameters 
Estimation of creatine kinase myoglobin (CK-MB) 
activity 
Creatine kinase myoglobin (CK-MB) was estimated spectropho- 
tometrically according to the method of Lamprecht [17] . The 
sample (50µl) was added to cuvette containing 1 ml of imida- 
zole buffer consisting of adenosine-mono-phosphate (5.2mM), 
adenosine-di-phosphate (2.1mM), nicotinamide adenine dinu- 
cleotide phosphate (2.1mM), glucose-6-phosphate dehydroge- 
nase (1.6 U/l), creatine phosphate (31.2 mm) and N-acetyl cys- 
teine (21 mm). The cuvette containing of sample and imidazole 
buffer was incubated for 2 min at room temperature. Absorbance 
was recorded on 340 nm for 180 sec at every 60 sec. One unit of 
creatine kinase myoglobin isoenzyme is defined as the amount of 
enzyme that will transfer one µ mol of phosphate from phospho- 
creatine to adenosine diphosphate per min at pH 7.4 on 30oC. 
SGOT & SGPT assay 
Serum glutamate oxaloacetate transaminase (SGOT) and serum 
glutamate pyruvate transaminase (SGPT) were determined by 
the method of Reitman and Frankel [18] . 0.5ml of L-alanine 
(200mM) and 0.5ml of L-aspartate (200mM) were taken sepa- 
rately and pre incubated with 2mM of α ketoglutarate for 5 min 
at 37◦C. To this 0.1ml of serum was added and the volume was 
adjusted to 1.0ml with sodium phosphate buffer (pH 7.4; 0.1M). 
The reaction mixture was incubated for 30 and 60 min for SGPT 
and SGOT respectively. A 0.5ml of 2, 4-dinitrophenyl hydra zine 
(1mM) was added to the reaction mixture and left for 30 min at 
room temperature. Finally, the color was developed by the addi- 
tion of 5ml NaOH (0.4 N) and the product formed was read at 
505nm. 
 
Estimation of triglyceride 
The triglyceride (TG) contents was estimated by Foster et al. 
method [19]. Isopropanol (1.0 ml) was added to 0.1 ml of sample 
and mixed well, followed by 0.4g of alumina and shaken well for 
15 min. Centrifuged at 2000 rpm for 10 min and then 2.0ml of 
the supernatant was transferred to appropriately labelled tubes. 
The tubes were placed in a water bath at 65oC for 15 min for 
saponification after adding 0.6 ml of the saponification reagent. 
After cooling, 1.0 ml of sodium meta periodate was added fol- 
lowed by 0.5 ml of acetyl acetone reagent, after mixing the tubes 
at 65oC for 30 min. The contents were cooled and read at 430nm. 
 
Determination of total cholesterol 
The serum total cholesterol (TC) level was measured by Zlatkis 
et al method [20]. To 0.1 ml of the serum, 4.9 ml of ferric chlo- 
ride precipitation reagent was added and centrifuged for few 
minutes. The supernatant (2.5 ml) was mixed with ferric chlo- 
ride diluting reagent (2.5ml) and add 4 ml of concentrated sulfu- 
ric acid. Suitable aliquots of the standards were made upto 5 ml 
with ferric chloride diluting reagent with 4 ml of concentrated 
sulfuric acid. The optical density was measured at 560 nm. The 
cholesterol content was expressed as mg/dl of serum. 
 
Estimation of high density lipoprotein 
High density lipoprotein (HDL) was determined by Friedewald 
et al method [21]. Serum (1ml) was mixed with 0.1 ml of phos- 
photungstate reagent and 50µl of magnesium chloride reagent. 
The content was centrifuged at ambient temperature for 30 min- 
utes at 1500 rpm. Supernatant (0.1ml) was added to 4.9 ml of 
ferric chloride precipitating reagent, then it was mixed well and 
centrifuged. From this, 2.5 ml of supernatant was taken. An ice 
bath was set. 2.5 ml of diluting reagent and 4 ml of concentrated 
sulphuric acid were added by thorough mixing. Various concen- 
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trations of working standard solution were taken to which 5ml 
diluting reagent, and 4 ml of sulphuric acid were added. A blank 
was also maintained. The colour developed was read at 560nm. 
Estimation of low-density lipoprotein cholesterol 
The serum level of low-density lipoprotein cholesterol (LDL) -C 
was measured according to the protocol of Friedewald et al. [22] 
using the relationship as follows: 
LDL-C = TC-TGL/5 + HDL-C 
Where LDL-C is low-density lipoprotein cholesterol, TC is 
total cholesterol, TGL is triglyceride and HDL-c is high-density 
lipoprotein. The value was expressed in mg/dl. 
Estimation of very low density lipoproteins 
The very low density lipoproteins (VLDL) contents were esti- 
mated by Friedewald et al method [22]. Serum (1 ml) was mixed 
with 0.15 ml of sodium dodecyl sulfate (SDS) solution. The con- 
tents were mixed well and incubated at 37ºC for 2 hrs. The con- 
tents were centrifuged in a refrigerated centrifuge at 10,000 g for 
30 min. VLDL C for 2 hrs. VLDL aggregates as pellicle at the 
top. The supernatant was a mixture containing HDL and LDL 
fraction. The values were expressed as mg/dl. 
LDL Cholesterol  = 
T otal Serum Cholesterol     (T otal serum T GL –HDL Cholesterol) 
5 
VLDL = Total serum TGL 
                           5 
 
Plasma LDH 
Plasma LDH was estimated by the method of Moldeus et al. 
(1978) [16]. Cuvettes (1 ml) in potassium phosphate buffer (pH 
7.0) using 20 µl sample. Reduction in NADH was monitored at 
340 nm against the appropriate controls every 15 s for 60 s. Data 
were expressed as mU/mL. 
Plasma TBARS 
Lipid peroxidation was measured by the method of Liu et al [23]. 
Reagents acetic acid 1.5 ml (20%, pH 3.5), 1.5 ml of thiobarbi- 
turic acid (0.8%) and 0.2 ml of sodium dodecyl sulphate (8.1 %) 
were added to 0.1 ml of supernatant, then heated at 100◦C for 
60 min. The above mixture was cooled and 5 ml of n-butanol- 
pyridine (15:1) mixture, 1 ml of distilled water were added and 
vortexed vigorously. After centrifugation at 4000 rpm for 10 
min, the organic layer was parted and absorbance was recorded 
at 532 nm. The calculation was performed using a molar ex- 
tinction coefficient of 1.56 ×105M−1 cm−1and the data was ex- 
pressed as nM/mL. 
Estimation of protein 
Estimation of protein was pre´cised by the method of Lowry et 
al. [24]. Aliquots of the appropriately diluted serum (0.1ml to 
10ml by two serial dilutions) was prepared up to 1.0ml with wa- 
ter and 4.5ml of alkaline copper reagent was added to all the 
tubes comprising blank, containing 1.0ml water and standards 
containing aliquots of standard BSA and made up to 1ml with 
water. The tubes were incubated for 10 min at room tempera- 
ture. 0.5 ml was mixed to all the tubes and incubated for 20 min 
at room temperature. The blue colour settled was recorded at 
640nm. 
 
Biochemical estimation of markers of oxidative stress or 
cardioprotective activity 
Myocardial TBARS 
Lipid per oxidation was measured by the method of Liu et al. 
[23]. It  was calculated using  a molar  extinction  coefficient of 
1.56 ×105M−1  cm−1and expressed as nM/gram tissue  mass 
Myocardial SOD 
SOD activity was analyzed by the method described by Kakkaret 
al. (1984) [25]. Assay mixture contained 0.1 ml of super- natant,       
1.2 ml of sodium pyrophosphate buffer (pH 8.3, 0.052 M), 0.1 
ml of phenazine methosulphate (186 µm), 0.3 ml of  nitro blue 
tetrazolium, 300 µM, 0.2 ml of nicotinamide adenine 
dinucleotide reduced disodium salt, (NADH, 750 µM). 
Reactionwas started by addition of NADH. After incubation at 
30◦ C for 90 sec, the reaction was stopped by the addition of 0.1 
ml of glacial acetic acid. Reaction mixture was agitated 
dynamically with 4.0 ml of n-butanol. Mixture was set a side to 
stand for 10 min, centrifuged and butanol layer was separated. 
Colour inten- sity of the chromogen in the butanol was measured 
at 560 nm by spectrophotometrically and concentration of SOD 
was expressed as U/mg of protein. 
 
Myocardial catalase 
Myocardial catalase parameter was performed by the method of 
Aebi (1974) [26]. 0.1 ml of supernatant was supplemented to 
cuvette comprising 1.9 ml of 50 mm phosphate buffer (pH 7.0). 
Reaction was started by addition of 1.0 ml of freshly prepared 
30 mm H2O2. The rate of decomposition of H2O2 was measured 
spectrophotometrically at 240 nm. Activity of catalase was ex- 
pressed as U/mg of protein. Data were expressed as U/mg pro- 
tein. 
 
Myocardial reduced glutathione (GSH) 
Reduced glutathione was measured according to the method of 
Ellman (1959) [27]. Equal quantity of homogenate was mixed 
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with 10% trichloroacetic acid and centrifuged to separate the 
proteins. To 0.01 ml of this supernatant, 2 mL of phosphate 
buffer (pH 8.4, 0.3 M), 0.5 ml of 5, 5’-dithio, bis (2-nitrobenzoic 
acid) [DTNB] and 0.4 ml double distilled water was added. Mix- 
ture was vortex ed and the absorbance read at 412 nm within 15 
min. Data were expressed as µg/gram tissue mass. 
 
Myocardial GPx 
GPx activity was determined by the method described by Paglia 
& Valentine (1967) [28] and modified by Wendel (1981) [29]. 
The reaction mixture consisted of 400 µl 0.25 M potassium 
phosphate buffer (pH 7.0), 200 µl supernatant, 100 µl GSH (10 
mm), 100 µl NADPH (2.5 mm) and 100 µl glutathione reductase 
(6 U/ml). Reaction was in progress by adding 100 µl hydrogen 
peroxide (12 mm) and absorbance restrained at 366 nm at 1-min 
intervals for 5 min. It was calculated using a molar extinction co- 
efficient of 6.22 x 103 M−1cm−1. Data was expressed as mU/mg 
of protein. 
 
Histopathological study 
Paraffin sections of buffered formalin fixed heart samples were 
stained with hematoxyline and eosin. The sections were exam- 
ined under a light microscope and photomicrographs were taken. 
 
Statistical analysis 
The data were presented as mean ± SEM and analyzed using the 
one-way analysis of variance (ANOVA) procedure of Statistical 
analysis system followed by Dunnett’s Multiple Comparison test 
to identify significant differences of treated groups from the con- 
trol (p < 0.001), (p<0.01), (p<0.05). 
 
Results 
 
Percentage yield of extract 
The percentage yield of the methanol extract of Bougainvillea 
glabra was found to be 6.5 % w/w 
 
Acute toxicity study 
In acute toxicity study, no mortality or any signs of behavioral 
changes were observed throughout the 15 days period after sin- 
gle oral administration of Bougainvillea glabra up to the dose 
levels of 2000 mg /kg. 
 
Estimation of serum 
parameters CK-MB 
The activity of serum CK-MB was assessed as marker of car- 
diac injury. Isoproterenol induced group (Group II) resulted in 
the significant (P<0.01) elevation of CK-MB enzyme activity 
as compared to the control group (Group-I). Although not nor- 
malized, CK-MB activity was significantly (P<0.05) reduced by 
the extracts of both groups and standard, propranolol (Group-III) 
in the following order. Propranolol (Group-III) > Bougainvillea 
glabra at 500 mg/kg (Group-V) >Bougainvillea glabra at 250 
mg/kg (Group-IV). The result was mentioned in table 1. 
 
SGOT activity 
The activity of enzyme marker SGOT was increased signifi- 
cantly (P<0.01) in isoproterenol treated rats (group II) when 
compared to normal control group rats. Rats fed with the 
Bougainvillea glabra plant extract (group IV & V) and propra- 
nolol treated rats (group-III) have shown a significant (P<0.05; 
P<0.05) decrease in SGOT levels as shown in table 1. 
 
SGPT activity 
The SGPT level was slight significant (p < 0.05) reduced in rats 
fed with Bougainvillea glabra extract at 250 mg /kg body weight 
(Group IV) when compared to the isoproterenol treated group 
(Group II). While more significant (p < 0.01) decrease was ob- 
served in the SGPT level in rats fed with Bougainvillea glabra 
extract at 500mg/kg body weight (Group V) and in propranolol 
treated group (Group-III). The result was shown in table 1. 
Values are mean ± s.d (n=6). Group-2 (isoproterenol in- 
duced) compared with group-1 (control rats). Groups-3 (propra- 
nolol), Groups- 4 (methanol extract of Bougainvillea glabra 250 
mg/kg), Groups- 5 (methanol extract of Bougainvillea glabra 
500 mg/kg) compared with group-2 (isoproterenol induced rats). 
** P< 0.01, *P< 0.05. 
 
Determination of serum triglyceride 
The activity of serum triglyceride was increased significantly 
(P<0.01) in isoproterenol treated rats when compared to normal 
control group rats. There was a significant (P<0.05; P<0.01) 
reduction of serum triglyceride levels were observed in two dif- 
ferent doses [i.e Bougainvillea glabra extract at 250 mg /kg body 
weight (Group-IV) and Bougainvillea glabra extract at 500 mg 
/kg body weight (Group-V)] when compared to the isoproterenol 
treated rats (Group-II). Noticeable significant (P<0.01) reduc- 
tion in serum triglycerides was seen in propranolol treated rats 
(Group-III) when compared with high dose, low dose and iso- 
proterenol treated rats (Group-II). The result was tabulated in 
table 2. 
 
Determination of serum total cholesterol 
The activity of serum total cholesterol was increased signifi- 
cantly (P<0.01) in isoproterenol treated rats when compared 
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Table 1 Effectof methanol extract of Bougainvillea glabra on CK-MB, SGOT and SGPT duringisoproterenol induced myocardial necrosis and oxidative 
stress in rats. 
 
 
 
 
 
 
 
 
 
(Propranolol + Isoproterenol) 
 
(BG-250mg/kg + Isoproterenol) 
(BG-500mg/kg + Isoproterenol) 
 
 
to normal control group rats. There was a significant (P<0.05; 
P<0.05) reduction of serum total cholesterol level was observed 
when methanol extract of Bougainvillea glabra at two differ- 
ent doses of i.e 250 mg /kg body weight (Group-IV) and 500 
mg /kg body weight (Group-V), respectively. Drastic signifi- 
cant (P<0.01) reduction was seen in rats treated with propra- 
nolol (Group-III) when compared to the isoproterenol treated 
rats (Group-II). The results was indicated in table 2. 
 
Estimation of high density lipoprotein 
The administration of methanol extract of Bougainvillea glabra 
caused significant (p<0.05; p<0.05) increase of HDL levels at 
500 mg/kg (Group-V) and 250 mg/kg body weight (Group-IV) 
when compared with isoproterenol treated rats (Group-II). How- 
ever, the level of HDL was found to be significant (p<0.01) and 
highly increased at the doses 10 mg/kg body weight with pro- 
pranolol (Group-III) as shown in table 2. 
 
Estimation of low-density lipoprotein 
The parameter low-density lipoprotein (LDL) exhibited a 
significant (p<0.01) elevation upon isoproterenol treatment 
(Group-II). The pretreatment of Bougainvillea glabra was sig- 
nificantly (p<0.05) prevented the elevation of these parameters 
in all the groups of rats. The effect of propranolol (Group-III; 
p<0.05) was more significant (p<0.01) and prominent than with 
Bougainvillea glabra plant extract 250 mg/kg (Group-IV) and 
500 mg/kg body weight (Group-V), as shown in table 2. 
 
Estimation of very low-density lipoprotein 
The activity of very low-density lipoprotein was increased sig- 
nificantly (p<0.01) in isoproterenol treated rats when compared 
to normal control group rats. Bougainvillea glabra at two differ- 
 
ent doses of 250 mg/kg body weight (Group IV) and 500 mg/ 
kg body weight (Group V) were significantly (p<0.05; p<0.01) 
reduced the increased levels of very low density lipoproteins. 
Propranolol (10mg/ kg body weight, Group-III) has shown more 
significantl (p<0.01) effect than the plant extract. The result was 
shown in table 2. 
Values are mean ± s.d (n=6). Group-2 (isoproterenol in- 
duced) compared with group-1 (control rats). Groups-3 (propra- 
nolol), Groups- 4 (methanol extract of Bougainvillea glabra 250 
mg/kg), Groups- 5 (methanol extract of Bougainvillea glabra 
500 mg/kg) compared with group-2 (isoproterenol induced rats). 
** P< 0.01, *P< 0.05. 
 
Plasma LDH 
Plasma LDH was increased significantly (p< 0.01) in iso- 
proterenol induced group (Group-II) in comparison to control 
(group-1) as shown in figure 4. Significant (p< 0.01) reduc- 
tion of LDH was observed only in group-V (methanol extract of 
Bougainvillea glabra at 500 mg/kg) and standard drug propra- 
nolol treated rats (Group-III) when compared with other groups. 
However, less significant (p<0.05) decrease of plasma LDH was 
observed with methanol extract of Bougainvillea glabra at 250 
mg/kg (group IV). Further, more significant (p<0.01) decrease 
in plasma LDH value was marked in propranolol treated rats. 
The results were indicated in figure 4. 
 
Plasma TBARS 
The methanol extract of Bougainvillea glabra treated groups IV 
and V were significantly (p< 0.05 and p< 0.001) decreased   
the level of plasma TBARS when compared with isoproterenol 
induced group (Group-II) as shown in figure 2. Isoproterenol 
induced  (group-II)  animals  showed  significantly  (p<  0.001) 
Groups CK-MB SGOT SGPT 
 (IU/mg of protein) (IU/mg of protein) (IU/mg of protein) 
Group I 
(Normal Control) 
90.2±9.12 17.54±0.66 24.28±0.89 
Group  II 
(Isoproterenol Control) 
189.3±2.50** 103.86±0.71** 92.7±1.01** 
Group III 123.4±3.67** 55.67±0.91** 47.2±0.81** 
Group IV 168.2±4.67* 
Group V 144.3±1.85** 
29.11±0.18* 
37.81±0.97** 
29.71±0.85* 
36.6±0.41** 
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Table 2 Effectof methanol extract of Bougainvillea glabra on TC, TG, HDL, LDL and VLDLduring isoproterenol induced myocardial necrosis and 
oxidative stress in rats. 
 
 
 
 
 
 
 
 
 
(Propranolol + Isoproterenol ) 
 
(BG-250mg/kg + Isoproterenol) 
 
(BG 500mg/kg+ Isoproterenol) 
 
 
 
Figure 1 Effect of methanol extract of Bougainvillea glabraon myocardial level of TBARS (nM/g of tissue) and myocardial level of CAT (U/mgof 
protein) during isoproterenol induced oxidative stress in rats. Values aremean ± s.d (n=6). Group-2(isoproterenol induced) compared with group-1 
(control rats). Groups- 3 (Propranolol),Groups- 4 (methanol extract of Bougainvillea glabra 250 mg/kg), 5(methanol extract of Bougainvillea glabra 
500 mg/kg) compared withgroup-2 (isoproterenol induced rats). ∗∗P< 0.01, ∗P< 0.05. 
Figure 2 Effect of methanol extract of Bougainvillea glabraon plasma TBARS (nM/mL) and myocardial level of SOD (U/mg of protein) 
duringisoproterenol induced oxidative stress in rats. Values are mean ± s.d (n=6). Group-2 (isoproterenol induced)compared with group-1 (control 
rats). Groups- 3 (Propranolol), Group-4(methanol extract of Bougainvillea glabra 250 mg/kg), Group-5 (methanolextract of Bougainvillea glabra 
500 mg/kg) when compared with group-2(isoproterenol induced rats). ∗∗P< 0.01, ∗P< 0.05. 
Groups TC TG HDL LDL VLDL (mg/dl) 
 
Group I 
(Normal Control) 
(mg/dl) 
150.63±1.91 
(mg/dl) 
132.34±0.98 
(mg/dl) 
23.8±2.12 
(mg/dl) 
32.79±1.17 
 
5.78±0.67 
Group II 
(Isoproterenol + Control) 
287.31±1.03** 209.7±3.89** 10.56±0.78** 88.16±2.04** 11.16±1.04** 
Group III 154.23±1.3** 165.76±7.5** 25.69±1.5** 49.72±1.5** 7.56±1.6** 
Group IV 188.55 ±1.5* 197.59±2.12* 16.67±0.72* 62.79±1.80* 9.46±0.88* 
Group V 162.29±1.89** 172.82±1.34** 21.38±1.25** 54.34±1.56** 8.53±0.24** 
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Figure 3 Effect of methanol extract of Bougainvilleaglabra on myocardial level of GSH (µg/ g of tissue) and myocardial level ofGPX (mU/mg of 
protein) during isoproterenol induced oxidative stress in rats.Values are mean ± s.d (n=6). Group-2(isoproterenol induced) compared with group-1 
(control rats). Groups-3(Propranolol), Groups- 4 (methanol extract of Bougainvillea glabra 250mg/kg), 5 (methanol extract of Bougainvillea glabra 
500 mg/kg) comparedwith group-2 (isoproterenol induced rats). ∗∗ P< 0.01, ∗P< 0.05. 
Figure 4 Effect of methanol extract of Bougainvilleaglabra on myocardial level of GSH (µg/ g of tissue) and myocardial level ofGPX (mU/mg of 
protein) during isoproterenol induced oxidative stress in rats.Values are mean ± s.d (n=6). Group-2(isoproterenol induced) compared with group-1 
(control rats). Groups-3(Propranolol), Groups- 4 (methanol extract of Bougainvillea glabra 250mg/kg), 5 (methanol extract of Bougainvillea glabra 
500 mg/kg) comparedwith group-2 (isoproterenol induced rats). ∗∗ P< 0.01, ∗P< 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 (Normal) (A) Light micrograph of control rat heart. Normal architectureof myocytes (H&E, 10X) 
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Figure 6 (Induced) (B) Isoproterenol (ISO) group showing focal confluent necrosisof muscle fiber with acute and chronic inflammation and 
myophagocytosis alongwith extravasation of red blood cells (10X, H&E). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 (C) Bougainvillea glabra extract (250 mg/kg) + Isoproterenol(ISO) group, showing focal necrosis of muscle fiber with acute and 
chronicinflammation (10X H&E) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 (D)Bougainvillea glabra extract (500 mg/kg) + Isoproterenol (ISO) group,showing occasional loss of muscle fiber with focal acute and 
chronicinflammation (10X H&E). 
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increased plasma TBARS level than the control treated rats 
(Group-I). Propranolol treated rats (Group-III) has shown more 
significant (p<0.01) decrease in plasma TBARS compared with 
groups IV and V, respectively. The result was mentioned in fig- 
ure 2. 
 
Myocardial TBARS 
There was significant (p< 0.001) increase in myocardial TBARS 
in the group-II (isoproterenol induced rat) when compared with 
group-I (control). Significant (p< 0.01; p< 0.05; p< 0.01) de- 
crease in the level of myocardial TBARS was observed in groups 
III and IV and V in comparison to the isoproterenol induced rats 
(Group-II). The result was exposed in figure 1. 
 
Myocardial SOD 
Significant (p<0.01) reduction of myocardial SOD activity was 
observed in group II (isoproterenol induced rat), when com- 
pared to control group (group-I). Myocardial SOD increased sig- 
nificantly (p<0.01) in rats treated with propranolol 10 mg/kg 
(group-III) and 500 mg/kg methanol extract of Bougainvillea 
glabra (group-V) as shown in figure 2. However, there was less 
significant (p< 0.05) increase in the level of myocardial SOD ac- 
tivity in methanol extract of Bougainvillea glabra at 250 mg/kg 
(group-IV). The result was mentioned in figure 2. 
 
Myocardial catalase 
In isoproterenol induced group of rats (group-II), there was a 
significant (p< 0.001) decrease in myocardial catalase activity 
compared to control group (Group-I). In group IV, there was 
less significant (p<0.05) increase in the level of myocardial 
catalase activity compared to isoproterenol induced rat (group- 
II). However, more significant (p< 0.01) increase in myocardial 
catalase activity was seen in group-V. However, significant (p< 
0.01) increased level of myocardial catalase was seen propra- 
nolol treated rats (group-III), as shown in figure 1. 
  Myocardial GSH 
In group-II, significantly (p< 0.01) decreased myocardium GSH 
was observed in comparison to control rats (group I). There was 
less significant increase (p< 0.05) and change in GSH levels   
in group-IV (methanol extract of Bougainvillea glabra at 250 
mg/kg) following isoproterenol administrations, when compared 
to group II (isoproterenol induced). However, more significant 
(p< 0.01) increase in myocardial GSH activity was observed in 
rats administered with propranolol (group-III) and methanol ex- 
tract of Bougainvillea glabra at 500 mg/kg (group V). The result 
was indicated in figure 3. 
 
Myocardial GPX 
Significant (p< 0.001) reduction in GPX activity was observed 
in isoproterenol-induced rats without treatment of plant extracts 
(Group-II). Animals of group III exhibited greater significant 
(p< 0.05) increase in myocardial GPX activity when compared 
to isoproterenol-induced rat group (Group-II). However, there 
was significant (p<0.01) change and increase of GPX activity 
was observed in group IV and V in comparison to isoproterenol 
induced rat group. But change was less than the propranolol 
treated rats (group-III) as shown in figure 3. 
 
Histopathology (Light microscopic study) 
Figure 5 (A), shows the H&E light micrograph of control heart 
showing normal architecture. There was confluent necrosis of 
cardiac muscle fibers with infiltration of acute and chronic in- 
flammatory cells along with extravasation of red blood cells in 
isoproterenol induced group [Figure 6 (B)]. In group- II, there 
was focal necrosis of muscle fibers with acute and chronic in- 
flammation [Figure 7 (C)]. However, there was only occasional 
loss of myofibers and inflammation was observed in groups III, 
IV and V with minimal in comparison to other groups [Fig-   
ure 8 (D)]. Myocardial necrosis was also unremarkable in those 
groups. [Figure 9 (E)] Propranolol, showing occasional loss of 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 (E)Propranolol, showing occasional loss of muscle fiber with focal acuteand chronic inflammation (10X H&E). 
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muscle fiber with focal acute and chronic inflammation (10X 
H&E). 
 
Discussion 
Isoproterenol is a catecholamine it undergoes auto oxidation re- 
sulting in the formation of free radicals which causes failure of 
ATP dependent sodium and potassium channels, calcium over- 
load, attack of cellular proteins, attack on the carbon linkage of 
polyunsaturated fatty acids [30] [31] . The consequence follow- 
ing a free radical attack is cell death resulting in necrosis of   
the cardiac tissue. Generation of free radicals by isoproterenol 
is considered as the causative factor for cardiotoxicity [32] . 
Thus, the determination of CK-MB isoenzyme is a useful pa- 
rameter for assessing myocardial damage. Pretreatment with 
Bougainvillea glabra prevented depletion of CK-MB isoenzyme 
from heart as compared to isoproterenol group. Therefore, ad- 
ministration of Bougainvillea glabra plant extract reduced the 
release of CK-MB isoenzyme from myocardium into the sys- 
temic circulation, an indicative part of cardioprotective action of 
Bougainvillea glabra. Myocardial necrosis leads to rise of car- 
diac serum marker enzymes such as SGOT and SGPT that are 
liberated from the heart into blood [32] and indicating substan- 
tial cardio cellular injury [33] . Administration of methanol ex- 
tract of Bougainvillea glabra at two different doses lowered the 
increased levels of the serum enzymes and produced a conse- 
quent recovery towards normalization when compared to con- 
trol group animals. Isoproterenol induced elevation in choles- 
terol levels could be due to increase in biosynthesis of choles- 
terol and decrease in its utilization. Isoproterenol induces free 
radical formation, which may cause cellular cholesterol accu- 
mulation in the body by increasing cholesterol biosynthesis, it 
also causes reduced cholesterol ester hydrolysis and also by re- 
ducing cholesterol efflux. Pretreatment with the plant extract of 
Bougainvillea glabra restored the level of cholesterol in the body 
and reduces the elevated levels of cholesterol. Increase in lipid 
profile like triglycerides, LDL, VLDL and decreased HDL level 
in isoproterenol treated rats indicate that isoproterenol may be 
interfering with metabolism or biosynthesis of lipids. [34] The 
increased myocardial triglycerides content observed in ISO in- 
duced myocardial infracted rats is because of increased uptake of 
LDL from the blood by myocardial membranes [35] . A strong 
positive correlation has been documented between the risk of 
developing ischemic heart disease and serum LDL level; where 
as a negative correlation has been reported with HDL choles- 
terol [36] . Pretreatment with Bougainvillea glabra shows re- 
duction in total cholesterol, triglycerides, LDL, VLDL and in- 
crease in HDL was observed. Decreased lipid profiles and in- 
crease HDL in Bougainvillea glabra treated groups may be due 
to presence of some bioactive compounds in plants. LDH has 
been used traditionally as a nonspecific diagnostic tool for my- 
ocardial infarction. A rise in the proportion of LDH can be diag- 
nostic of myocardial infarction [34]. Administration of methanol 
extract of Bougainvillea glabra at two different doses lowered 
the increased level of the plasma LDH and produced a conse- 
quent recovery towards normalization when compared to control 
group animals. In isoproterenol induced cardio toxicity, oxida- 
tive stress is caused as result of the imbalance between endoge- 
nous antioxidants and free radicals of isoproterenol. It is already 
known that lipids are the most susceptible macro molecules to 
oxidative stress and our results showed that the level of lipid per- 
oxides, measure in term of TBARS was significantly increased 
in plasma and heart of isoproterenol treated group. Bougainvil- 
lea glabra pretreatment in the present decreases the level of 
plasma and myocardial lipid peroxides by an apparent direct 
scavenging of superoxide and hydroxyl radicals and by inacti- 
vating the enzyme cyclo-oxygenase [37] . Superoxide dismutase 
(SOD) is another reactive oxygen species (ROS) defense en- 
zyme present exclusively in the mitochondrial matrix and pro- 
tects cells against the deleterious effects of super oxide anion 
derived from the per oxidative process in tissues. The observed 
enhancement in SOD activity might be due to the scavenging of 
free radicals by methanol extract of Bougainvillea glabra. How- 
ever, when treated with, low dose and high dose of Bougainvil- 
lea glabra methanol extract the groups showed significant ele- 
vation in the level of these enzymes, which denotes the antiox- 
idant activity of the Bougainvillea glabra. Catalase is a peroxi- 
somal enzyme present in the mitochondria of the heart. It is one 
of the antioxidant defense enzymes which plays an indispens- 
able role in the oxidation of hydrogen peroxide to oxygen and 
water [26]. In the present study, catalase activity was decreased 
and then restored to normal levels on administration of methanol 
extract of Bougainvillea glabra. In case of non enzymic antiox- 
idants, GSH is a critical determinant of tissue susceptibility to 
oxidative damage. Decrease in cardiac GSH has been correlated 
with the enhanced toxicity of chemicals, including isoproterenol 
on living tissues [38]. The increase in myocardial GSH level   
in the rats treated with, 250 and 500 mg/kg of Bougainvillea 
glabra methanol extract may be due to synthesis or regenera- 
tion of GSH. The glutathione antioxidant system, GPx plays     
a crucial function in cellular resistance against oxidative stress 
by continuation a cascade of reactions. Glutathione peroxidase 
(GPx) is a selenoprotein that oxidizes two molecules of glu- 
tathione (GSH) into oxidized glutathione (GSSG). This oxida- 
tion is favoured by the configuration of a disulphur bond. The 
lessening in enzymatic GPx in isoproterenol treated rats might 
be due to the influence of free radicals on antioxidant arrange- 
ment. In current study, GPx levels depleted by isoproterenol 
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were significantly prominent by methanol extract of Bougainvil- 
lea glabra. Methanol extract of Bougainvillea glabra produced 
cardioprotection at different dose levels. However 500mg/kg 
was found to be more effective than the lower dose. Histopathol- 
ogy study clearly indicated the extent of myocardial necrosis by 
showing variations for isoproterenol and other groups treated 
by two doses of Bougainvillea glabra and propranolol. Degree 
of myocardial necrosis and loss of muscle fiber were signifi- 
cantly less in methanol extract of Bougainvillea glabra and pro- 
pranolol treated groups form the light microscopic changes of 
histopathology study. 
 
Conclusions 
In conclusion, the results of  the  present  study  indicate that 
the prior administration of methanol extract of Bougainvillea 
glabra for 30 days prevents the isoproterenol induced myocar- 
dial necrosis in rats. The overall cardioprotective effect of plant 
extract is probably related to a counteraction of free radicals by 
its antioxidant property. Histopathological findings further con- 
firmed the cardiac protective effect of Bougainvillea glabra. 
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